131 related articles for article (PubMed ID: 20888654)
1. Antiarrhythmic agent cibenzoline attenuates latent obstruction in the left ventricular outflow tract of hypertrophic cardiomyopathy.
Nomura T; Kojima A; Urakabe Y; Enomoto-Uemura S; Nishikawa S; Keira N; Matsubara H; Tatsumi T
Int J Cardiol; 2011 May; 148(3):359-61. PubMed ID: 20888654
[No Abstract] [Full Text] [Related]
2. Hemolytic anemia in a patient with hypertrophic obstructive cardiomyopathy.
Kubo T; Kitaoka H; Terauchi Y; Tamura S; Okawa M; Yamasaki N; Yabe T; Doi YL
J Cardiol; 2010 Jan; 55(1):125-9. PubMed ID: 20122559
[TBL] [Abstract][Full Text] [Related]
3. Cibenzoline attenuates coronary systolic reversal flow in a patient with hypertrophic obstructive cardiomyopathy: a case report.
Saihara K; Hamasaki S; Otsuji Y; Yoshitama T; Ishida S; Kataoka T; Okui H; Tei C
J Cardiol; 2006 Oct; 48(4):209-13. PubMed ID: 17066624
[TBL] [Abstract][Full Text] [Related]
4. Effect of cibenzoline on biventricular pressure gradients in a pediatric patient with hypertrophic obstructive cardiomyopathy.
Ishikawa T; Iwashima S; Ohzeki T
Pediatr Cardiol; 2010 Jul; 31(5):707-10. PubMed ID: 20140606
[TBL] [Abstract][Full Text] [Related]
5. Effect of cibenzoline, a class ia antiarrhythmic agent, on left ventricular diastolic function in hypertrophic cardiomyopathy.
Kondo I; Mizushige K; Nozaki S; Iwado Y; Masugata H; Kohno M; Matsuo H
Cardiovasc Drugs Ther; 2001 Sep; 15(5):459-65. PubMed ID: 11855665
[TBL] [Abstract][Full Text] [Related]
6. Cibenzoline improves coronary flow velocity reserve in patients with hypertrophic obstructive cardiomyopathy.
Sekine T; Daimon M; Hasegawa R; Teramoto K; Kawata T; Tanaka N; Takei Y; Takazawa K; Yoshida K; Komuro I
Heart Vessels; 2006 Nov; 21(6):350-5. PubMed ID: 17143709
[TBL] [Abstract][Full Text] [Related]
7. Salutary effect of disopyramide on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy.
Matsubara H; Nakatani S; Nagata S; Ishikura F; Katagiri Y; Ohe T; Miyatake K
J Am Coll Cardiol; 1995 Sep; 26(3):768-75. PubMed ID: 7642872
[TBL] [Abstract][Full Text] [Related]
8. Antiarrhythmic drug cibenzoline attenuates left ventricular pressure gradient and improves transmitral Doppler flow pattern in patients with hypertrophic obstructive cardiomyopathy caused by midventricular obstruction.
Hamada M; Shigematsu Y; Inaba S; Aono J; Ikeda S; Watanabe K; Ogimoto A; Ohtsuka T; Hara Y; Higaki J
Circ J; 2005 Aug; 69(8):940-5. PubMed ID: 16041163
[TBL] [Abstract][Full Text] [Related]
9. Class Ia antiarrhythmic drug cibenzoline: a new approach to the medical treatment of hypertrophic obstructive cardiomyopathy.
Hamada M; Shigematsu Y; Ikeda S; Hara Y; Okayama H; Kodama K; Ochi T; Hiwada K
Circulation; 1997 Sep; 96(5):1520-4. PubMed ID: 9315541
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effect of cibenzoline on left ventricular pressure gradient with sigmoid septum.
Konishi C; Shiraishi J; Muraguchi N; Ohtsuki K; Inoue M; Tatsumi T; Azuma A; Matsubara H
Circ J; 2004 Oct; 68(10):968-71. PubMed ID: 15459474
[TBL] [Abstract][Full Text] [Related]
11. A primer of disopyramide treatment of obstructive hypertrophic cardiomyopathy.
Sherrid MV; Arabadjian M
Prog Cardiovasc Dis; 2012; 54(6):483-92. PubMed ID: 22687589
[TBL] [Abstract][Full Text] [Related]
12. Hypertrophic cardiomyopathy with mid-ventricular obstruction and splenic infarction associated with paroxysmal atrial fibrillation: a case report.
Tokuyasu K; Hara Y; Matsumoto Y; Hashida H; Ikeda S; Ohtsuka T; Hiasa G; Kitami Y; Shigematsu Y; Hamada M; Hiwada K
J Cardiol; 1999 Nov; 34(5):273-7. PubMed ID: 10579136
[TBL] [Abstract][Full Text] [Related]
13. Effect of cibenzoline and atenolol administration on dynamic left ventricular obstruction due to sigmoid-shaped septum.
Ozaki K; Sakuma I; Mitsuma K; Suzuki T; Tsuchida K; Takahashi K; Miida T; Oda H
Circ J; 2008 Dec; 72(12):2087-91. PubMed ID: 18854617
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of cibenzoline for chest oppression and ventricular arrhythmia during effort and alcohol consumption in a patient with hypertrophic obstructive cardiomyopathy: a case report].
Sasayama T; Horimoto M; Takeda T; Takenaka T; Inoue H; Igarashi K; Akino M; Kikuchi K
J Cardiol; 2000 Jun; 35(6):445-50. PubMed ID: 10884982
[TBL] [Abstract][Full Text] [Related]
15. A patient with hypertrophic obstructive cardiomyopathy presenting with left ventricular apical ballooning syndrome.
Jaber WA; Wright SR; Murphy J
J Invasive Cardiol; 2006 Oct; 18(10):510-2. PubMed ID: 17015918
[No Abstract] [Full Text] [Related]
16. An early systolic sound associated with midventricular obstruction in a patient with hypertrophic cardiomyopathy.
Ohtsuka T; Hamada M; Hara Y; Kuwahara T; Kodama K; Shigematsu Y; Iwata T; Hiwada K
Jpn Circ J; 1998 May; 62(5):385-8. PubMed ID: 9626909
[TBL] [Abstract][Full Text] [Related]
17. A rare combination of undiagnosed hypertrophic cardiomyopathy revealed by intraoperative anaphylaxis resulting in acute left ventricular outflow obstruction and cardiac arrest.
Smith BB; Nickels AS; Sviggum HP
J Clin Anesth; 2016 Jun; 31():212-4. PubMed ID: 27185714
[TBL] [Abstract][Full Text] [Related]
18. [Beneficial effect of cibenzoline in a patient with hypertrophic obstructive cardiomyopathy complicated with idiopathic interstitial pneumonia].
Saito M; Hara Y; Shigematsu Y; Ohtsuka T; Saeki H; Ogimoto A; Yokoyama A; Hamada M
Nihon Ronen Igakkai Zasshi; 2003 Jan; 40(1):62-4. PubMed ID: 12649850
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetic interactions between Angiotensin-converting enzyme insertion/deletion polymorphism and response to cibenzoline in patients with hypertrophic obstructive cardiomyopathy.
Ogimoto A; Okayama H; Nagai T; Ohtsuka T; Suzuki J; Inoue K; Nishimura K; Saito M; Shigematsu Y; Hamada M; Miki T; Higaki J
J Cardiovasc Pharmacol; 2010 May; 55(5):506-10. PubMed ID: 20179607
[TBL] [Abstract][Full Text] [Related]
20. [Muscular obstruction of the right ventricular outflow tract. Subvalvular pulmonary stenosis or hypertrophic cardiomyopathy?].
Schräder R; Hopf R; Eichwede F; Kneissl G; Olbrich HG; Reifart N; Schneider M; Oelert H; Kaltenbach M
Z Kardiol; 1987 Oct; 76(10):648-52. PubMed ID: 3687168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
